Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults

NCT05184062 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05184062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05184062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Completed
Start date
December 3, 2021
Completion date
May 6, 2023
Enrollment
272 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019 (covid-19)